The national growth rate for psychiatric medication spending has declined significantly, according to a new study conducted by researchers from Thomson Reuters (Healthcare) and the Substance Abuse and Mental Health Services Administration (SAMHSA).
Psychiatric Medication Spending Growth Slows, According to New Thomson Reuters Research
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment